Research advances of erianin: Source, production, biological activities and pharmacological properties
Qinghe Qiao, Yihao Du, Lihang Xie
Pharmacological Research - Modern Chinese Medicine · 2022
doi:10.1016/j.prmcm.2022.100059 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
As the major bibenzyl compound extracted from Chinese traditional medicine Dendrobium chrysotoxum Lindl., erianin possesses plenty of biological properties including antibacterial, antiviral, anti-oxidant, anti-inflammatory, and especially anti-cancer activities with low toxicity and high efficiency. However, the natural source of erianin from Dendrobium species is limited and unsustainable. The methods of extraction, separation and chemical synthesis of erianin have been studied and developed. Meanwhile, biosynthesis also provides an alternative strategy for artificial synthesis of erianin. In addition, the previous studies also confirmed that the various biological activities of erianin were achieved with multiple mechanisms. This review summarized the source, production, biological effects, and action mechanisms, which would provide a theoretical basis and reference for industrialized production and clinical application of erianin.
Abstract licence: CC BY-NC
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.